Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Tamoxifen lowered breast cancer rates among high-risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
16 Dec 2014

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer

Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014

CLL at ASH 2014: Expert discussion

Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014

BOLERO-1 reports HER2-positive breast cancer latest PFS data

Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014

Comment: Tamoxifen lowered breast cancer rates among high-risk women

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Tamoxifen lowered breast cancer rates among high-risk women ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014

Best of ASH 2014

Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014

ASH 2014: Highlights in CLL from ASH 2014

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger
ASH 2014: Highlights in CLL from ASH 2014 ( Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger )
8 Dec 2014

Oprozomib shows potential in the treatment of multiple myeloma

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA
Oprozomib shows potential in the treatment of multiple myeloma ( Dr Ravi Vij - Washington University School of Medicine, St Louis, USA )
8 Dec 2014

Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA
Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma ( Dr Ravi Vij - Washington University School of Medicine, St Louis, USA )
8 Dec 2014

Hope for avoiding chemo in patients with Hodgkins lymphoma

Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy
Hope for avoiding chemo in patients with Hodgkins lymphoma ( Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy )
8 Dec 2014

Combination therapy for high-risk MDS? Not quite yet

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Combination therapy for high-risk MDS? Not quite yet ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )
8 Dec 2014

ASH 2014: Highlights in mantle cell lymphoma

Prof Steven Le Gouill and Prof Simon Rule
ASH 2014: Highlights in mantle cell lymphoma ( Prof Steven Le Gouill and Prof Simon Rule )
8 Dec 2014